Allergy Therapeutics PLC on Tuesday said that a trial evaluating the efficacy of its subcutaneous allergen-specific immunotherapy candidate has met its primary endpoint.
Allergy Therapeutics is a.
ZQ Capital Management Ltd on Monday announced a mandatory takeover offer for Allergy Therapeutics PLC, as required under UK takeover rules, but it said the offer won t be accepted by the Allergy s.
/PRNewswire/ In-depth analysis provided in the report includes: Current and future market trends to highlight market conditions Comparative analysis of the.